Roxatidine in duodenal ulcer.

Roxatidine acetate is a new H2-receptor antagonist. A randomized double-blind clinical trial in fifty-three patients with endoscopically proven duodenal ulcers > 5 mm in diameter was undertaken to compare safety and efficacy of roxatidine with that of ranitidine. Twenty-six patients received...

Full description

Bibliographic Details
Main Authors: Habibullah C, Habeeb M, Singh S
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 1995-07-01
Series:Journal of Postgraduate Medicine
Subjects:
Online Access:http://www.jpgmonline.com/article.asp?issn=0022-3859;year=1995;volume=41;issue=3;spage=64;epage=5;aulast=Habibullah